Cre-Lox 툴박스 네비게이션 | 벡터빌더
Confounding influence of tamoxifen in mouse mod...
CreER-LoxP System-Based Target Gene Inactivatio...
Tamoxifen-dependent Cre expression, recombinati...
(PDF) Transgenic Mice for a Tamoxifen-Induced, ...
3. Tamoxifen inducible Cre-loxP system for cont...
Tamoxifen-induced Cre recombination reduces bot...
Inducible Cre/Lox systems. (A) Tamoxifen-induci...
Mechanism of Cre-loxP system. (A) An overview o...
Cre Lox Conditional Knockout
Cells undergoing Cre-induced recombination are ...
Tamoxifen (TM)-dependent and osteoblast-specifi...
Frontiers Cre-loxP-mediated Genetic Lineage Tra...
小鼠基础知识八:Tamoxifen诱导型cre | 杰克森实验室
(PDF) Cre recombinase expression or topical tam...
Tamoxifen-dependent Cre activation induces apop...
Expression of Cre recombinase, and characterisa...
Tamoxifen-inducible recombination in double tra...
(PDF) Tamoxifen Activation of Cre-Recombinase H...
The CreER/LoxP system. CreER is a tamoxifen-ind...
Optocontrolled Cre recombinase system for gene ...
(PDF) Optimizing tamoxifen-inducible Cre/loxp s...
CRE recombinase technology. The CRE recombinase...
Cre-Flex (Cre-mediated flip-excision) inducible...
Expression of Cre recombinase without tamoxifen...
Using conventional and tamoxifen-inducible Cre ...
Tamoxifen treatment for 3 –14 days is sufficien...
Tamoxifen regulated CreERT2 recombinase activit...
Figure 1 from Tamoxifen Activation of Cre-Recom...
Tamoxifen-inducible and tissue-specific recombi...
Floxed E8 and tamoxifen inducible Cre recombina...